LV11323A - Izohinolina atvasinajumi ka arstnieciskie lidzekli - Google Patents

Izohinolina atvasinajumi ka arstnieciskie lidzekli

Info

Publication number
LV11323A
LV11323A LV960014A LV960014A LV11323A LV 11323 A LV11323 A LV 11323A LV 960014 A LV960014 A LV 960014A LV 960014 A LV960014 A LV 960014A LV 11323 A LV11323 A LV 11323A
Authority
LV
Latvia
Prior art keywords
optionally substituted
pct
alkyl
alkoxy
hydroxy
Prior art date
Application number
LV960014A
Other languages
English (en)
Latvian (lv)
Inventor
Bruce J Sargent
David N Johnston
Andrew P A Crew
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939312807A external-priority patent/GB9312807D0/en
Priority claimed from GB939312808A external-priority patent/GB9312808D0/en
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of LV11323A publication Critical patent/LV11323A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/08Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
LV960014A 1993-06-22 1996-01-22 Izohinolina atvasinajumi ka arstnieciskie lidzekli LV11323A (lv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939312807A GB9312807D0 (en) 1993-06-22 1993-06-22 Therapeutic agents
GB939312808A GB9312808D0 (en) 1993-06-22 1993-06-22 Therapeutic agents
PCT/EP1994/001926 WO1995000489A1 (en) 1993-06-22 1994-06-10 Isoquinoline derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
LV11323A true LV11323A (lv) 1996-06-20

Family

ID=26303101

Family Applications (1)

Application Number Title Priority Date Filing Date
LV960014A LV11323A (lv) 1993-06-22 1996-01-22 Izohinolina atvasinajumi ka arstnieciskie lidzekli

Country Status (26)

Country Link
US (2) US5807868A (no)
EP (1) EP0707570B1 (no)
JP (1) JPH08511549A (no)
CN (1) CN1046713C (no)
AT (1) ATE165823T1 (no)
AU (1) AU679765B2 (no)
BG (1) BG62403B1 (no)
BR (1) BR9406897A (no)
CA (1) CA2165823A1 (no)
CZ (1) CZ290661B6 (no)
DE (1) DE69410093T2 (no)
DK (1) DK0707570T3 (no)
ES (1) ES2116601T3 (no)
FI (1) FI956150A (no)
HU (1) HU211157A9 (no)
LV (1) LV11323A (no)
MY (1) MY111699A (no)
NO (1) NO305434B1 (no)
NZ (1) NZ268587A (no)
PL (1) PL177947B1 (no)
RO (1) RO117377B1 (no)
RU (1) RU2135472C1 (no)
SK (1) SK280108B6 (no)
TW (1) TW353658B (no)
UA (1) UA42730C2 (no)
WO (1) WO1995000489A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
CA2295239A1 (en) 1997-06-27 1999-01-07 Fujisawa Pharmaceutical Co., Ltd. Sulfonamide compounds and medicinal use thereof
EP1023269A4 (en) * 1997-09-30 2001-06-27 Molecular Design Int BETA3-ADRENORECEPTOR AGONISTS, AGONIST COMPOSITIONS AND METHODS OF USE
MXPA02008797A (es) * 2000-03-14 2005-09-08 Actelion Pharmaceuticals Ltd Derivados de 1,2,3,4-tetrahidroisoquinolina.
US6593341B2 (en) 2001-03-29 2003-07-15 Molecular Design International, Inc. β3-adrenoreceptor agonists, agonist compositions and methods of making and using the same
US6596734B1 (en) 2002-10-11 2003-07-22 Molecular Design International, Inc. Tetrahydroisoquinoline compounds for use as β3-adrenoreceptor agonists
US7834184B2 (en) * 2004-11-04 2010-11-16 Mallinckrodt Inc. Opiate intermediates and methods of synthesis
US7511060B2 (en) 2005-10-21 2009-03-31 Mallinckrodt Inc. Opiate intermediates and methods of synthesis
US7622586B2 (en) * 2005-10-21 2009-11-24 Mallinckrodt Inc. Opiate intermediates and methods of synthesis
CN105585527B (zh) * 2015-12-17 2018-06-26 浙江工业大学 2-(3,4-二氢异喹啉-1(2h)-亚基)乙腈类化合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR868733A (fr) * 1939-10-14 1942-01-14 Troponwerke Dinklage & Co Procédé pour la fabrication des composés d'isoquinoleine
CH420086A (de) * 1962-01-19 1966-09-15 Hoffmann La Roche Verfahren zur Herstellung von Tetrahydroisochinolin-Derivaten
JPS5734275B2 (no) * 1973-07-30 1982-07-22
US4766131A (en) * 1980-10-17 1988-08-23 Pennwalt Corporation 2-amino (or hydroxy) phenethyl-1,2,3,4-tetrahydroisoquinolines as analgesics
IL63918A0 (en) * 1980-10-17 1981-12-31 Pennwalt Corp N-(amino(or hydroxy)phenethyl)-1,2,3,4-tetrahydroisoquinolines,their preparation and pharmaceutical compositions containing them
US4375471A (en) * 1981-02-19 1983-03-01 Hoechst-Roussel Pharmaceuticals Inc. 4-Aryloxy-1,2,3,4-tetrahydroisoquinolines
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
JP2716548B2 (ja) * 1989-11-01 1998-02-18 雅昭 廣部 パーキンソニズム予防・治療剤
GB9127306D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
FI956150A0 (fi) 1995-12-20
TW353658B (en) 1999-03-01
JPH08511549A (ja) 1996-12-03
PL177947B1 (pl) 2000-02-29
BR9406897A (pt) 1996-03-26
NZ268587A (en) 1998-01-26
NO955234L (no) 1996-02-21
WO1995000489A1 (en) 1995-01-05
BG100195A (bg) 1996-11-29
EP0707570A1 (en) 1996-04-24
ES2116601T3 (es) 1998-07-16
MY111699A (en) 2000-11-30
CZ290661B6 (cs) 2002-09-11
EP0707570B1 (en) 1998-05-06
UA42730C2 (uk) 2001-11-15
CN1128992A (zh) 1996-08-14
PL312251A1 (en) 1996-04-01
DE69410093D1 (de) 1998-06-10
NO305434B1 (no) 1999-05-31
DK0707570T3 (da) 1998-10-07
US5807868A (en) 1998-09-15
SK160495A3 (en) 1996-11-06
CZ342795A3 (cs) 2000-04-12
US5804586A (en) 1998-09-08
ATE165823T1 (de) 1998-05-15
NO955234D0 (no) 1995-12-21
SK280108B6 (sk) 1999-08-06
CA2165823A1 (en) 1995-01-05
CN1046713C (zh) 1999-11-24
RU2135472C1 (ru) 1999-08-27
RO117377B1 (ro) 2002-02-28
HU211157A9 (en) 1995-10-30
DE69410093T2 (de) 1998-10-01
AU679765B2 (en) 1997-07-10
BG62403B1 (bg) 1999-10-29
FI956150A (fi) 1995-12-20
AU7185194A (en) 1995-01-17

Similar Documents

Publication Publication Date Title
GEP19970661B (en) Process for preparing arylcyclobutyl alkylamine derivatives
ATE178588T1 (de) Amidino-derivate und ihre verwendung als no- synthase inhibitoren
ATE85976T1 (de) Pharmakologisch aktive derivate von tryptophan und diese enthaltende pharmazeutische zusammensetzungen.
FI952204A (fi) Terapeuttisia aineita
LV11323A (lv) Izohinolina atvasinajumi ka arstnieciskie lidzekli
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
BR9507231A (pt) Uso de derivados de ácido carboxílico para a produção de drogas
BR1100306A (pt) Compostos, composições farmacêuticas, uso de um composto e processo para preparação de compostos
DE69122858D1 (de) Therapeutische benzazepin verbindungen
KR927003537A (ko) 4, 5-사이클로알카노-3-벤즈아제핀-7-올 유도체 및 이의 용도
ES8504103A1 (es) Un procedimiento para preparar derivados de ciclobutano
JO1815B1 (en) Therapeutic agents
DE69615657D1 (de) Antifungal fusacandine
MY108027A (en) Substitute tetrahydroisoquinolines and use as therepuetic agents
JO1758B1 (en) Therapeutic agents
ES2120039T3 (es) Nuevos acildipeptidos heterociclicos, procedimientos de preparacion y composiciones farmaceuticas que los contienen.
KR970704686A (ko) 비시클로락탐 화합물, 그 용도 및 그 제조중간체(bicyclolactam compounds, use of the same and intermediate in the production of the same)
RU94038051A (ru) Гетероциклические производные, способ их получения, фармацевтическая композиция и способ лечения
KR950703962A (ko) 중추 신경계 질병을 치료하기 위한 트리아 졸로퀴나졸린(Triazoloquinazolines for the Treatment of Diseases of the Central Nervous System)